Xylem Inc (NYSE:XYL) currently has a daily average trading volume of 1.67M but it saw 2165358 shares traded in last market. With a market cap of 26.20B USD, the company’s current market price of $107.68 came falling about -2.55 while comparing to the previous closing price of $110.50. In past 52 weeks, the stock remained buoying in the range of price level as high as $146.08 and as low as $100.47. In the recent trading on the day, stock has struck highest price mark of $104.14 while lowest mark touched by it was $109.125.
Taking a look at 20-day trading activity of Xylem Inc (XYL) gives us an average price of $116.68, while its current price level is -26.29% below from 52-week high level whereas it is 7.17% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $123.64 while that of 200 days or SMA-200 reads an average of $127.57. A closer look into the stock’s movement over the week reveals that its volatility is standing at 6.59% during that period while stretching the period over a month that decreases to 3.16%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 34.79 which implies that the stock is in neutral territory.
Citigroup upgraded its recommendation for the stock as a “Buy” from “Neutral” on December 09, 2024 while assigning a price target range of $135-$148. TD Cowen also issued its recommendations for the stock as it downgraded the price target for the stock is $138.
Over the week, XYL’s stock price is moving -2.98% down while it is -12.35% when we observe its performance for the past one month. Year-to-date it is -7.19% down and over the past year, the stock is showing a downside performance of -16.48%.
The company is expected to be releasing its next quarterly report on 2025-Feb-03, for which analysts forecasted an EPS of 0.95 while estimate for next year EPS is 4.65. In next quarter, company is expected to be making quarterly sales of $2.19B as analysts are expecting the sales for current fiscal year at $8.73B and seeing the company making $9.2B in sales next year. Moreover, analysts are in estimates of $2.04B for current-quarter revenue.
Currently, Xylem Inc’s total number of outstanding shares is 242.99M with 0.22% of that held by the insiders while 96.55% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 6.92% and return on equity (ROE) at 8.55%. It has a price to earnings ratio (P/E ratio) of 29.47 while having a 20.60 of forward P/E ratio. Stock’s beta reads 1.11. Stock has a price to book (P/B) ratio of 2.46 while price to sale or P/S ratio amounts to 3.06. Its return on asset (ROA) is 5.46% on average.
